openPR Logo
Press release

Dr. Tristan Maurer to Discuss Translational Modeling in Support of Drug Discovery in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

12-10-2011 09:16 AM CET | Science & Education

Press release from: Rosa and Co

Rosa Logo

Rosa Logo

Rosa & Co. LLC today announced that Dr. Tristan Maurer, Pfizer Inc., will present a webinar “Translational Modeling & Simulation in Support of Rational Drug Discovery: Principles, Challenges, and Examples” on Tuesday, December 13, 2011 at 1:00 to 2:00 pm EST as part of Rosa’s ongoing monthly public webinar series. The purpose of the series, “Impact of Modeling & Simulation in Drug Development”, is to foster the use of Modeling and Simulation (M&S) activities in biotechnology, pharmaceutics, and other life science industries. This series is geared to illustrate the advantages and applicability of M&S in product discovery, development, and marketing programs. Dr. Maurer’s talk, “Translational Modeling & Simulation in Support of Rational Drug Discovery: Principles, Challenges, and Examples”, will focus on the use of modeling and simulation in support of drug discovery.
“One of the most serious threats to sustained pharmaceutical innovation is the rapidly rising cost of research and development experienced over the past several decades. This exponential rise in cost has been attributed to a variety of factors including increasing technology investments, rising regulatory and commercial hurdles, and higher attrition rates. Among these factors, attrition due to insufficient efficacy and / or safety stands out as a major contributor. Historically high rates of efficacy and safety related attrition suggest that that there is often insufficient knowledge upon which critical decisions in drug discovery are made, namely: which biochemical targets to pursue and which chemical matter to bring forward into the clinic. Preclinical modeling and simulation (e.g. systems biology, PK/PD) is a useful approach to integrating biological information toward the selection of the most promising targets and the design of the most promising chemical matter. As such, over the past several years, quantitative modeling and simulation has become increasingly popular among pharmaceutical companies seeking to reduce attrition. This presentation will provide the rationale for quantitative modeling and simulation, guiding principles for successful implementation of fit for purpose models, and examples illustrative of value added in drug discovery.”

Register for this free webinar at www.rosaandco.com/webinar. After registering, a confirmation email will be sent with directions for joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at www.rosaandco.com/webinar.

Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these approaches, Rosa’s clients collaborate in model creation and testing, retain the final model, and acquire the ability to use it and understand its implications for their drug development programs. Rosa’s staff have close to two decades of unparalleled professional experience in using drug-disease modeling and simulation (M&S) to accelerate drug development; they have covered hundreds of applications with dozens of clients. The Rosa team is unique in their breadth and depth of disease area experience, which includes metabolic and cardiovascular diseases, oncology, gastro-intestinal disease, inflammatory diseases, immune dysfunction (including rheumatoid arthritis), pain, skin conditions, respiratory disorders, and antibacterials/antivirals. For more information, visit www.rosaandco.com.

751 Laurel St., Ste. 127,
San Carlos, CA 94070

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dr. Tristan Maurer to Discuss Translational Modeling in Support of Drug Discovery in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development” here

News-ID: 203414 • Views:

More Releases for Modeling

Global Drug Modeling Software Market Overview Analysis
Stratistics MRC’s Drug Modeling Software Market report explains company profiling, key segments, market trends, top players and regional, country-level segments. Drug modeling software is used to develop new pharmaceutical drugs and test whether it is effective in treating a particular disease. It is an essential tool in the drug design process as it provides insights of experimental findings and mechanisms of action. Browse complete “Drug Modeling Software Market” report with TOC @
Software & System Modeling Tools Market by Type (Standard language-based Modelin …
ReportsWeb.com has announced the addition of the “Global Software & System Modeling Tools Market Size Status and Forecast 2022” The report classifies the global Software & System Modeling Tools Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Software & System Modeling Tools market, analyzes and researches the Software & System Modeling Tools development
Building Information Modeling Market - Growth Techniques 2025
Global Building Information Modeling Market: Overview Building information modeling (BIM) is a process based on intelligent 3D modeling that helps in the more efficient management, construction, designing, and planning of infrastructure and buildings. BIM allows construction, engineering, and architecture professionals to gain a decisive insight and get equipped with powerful tools for streamlining their projects. BIM is considered effective in upgrading a project’s work quality and productivity and complying with commercial
3D Mapping and 3D Modeling Market - Increasing Demand For 3D Mapping and Modelin …
3D mapping and 3D modeling solutions are used across various end-user industries such as video entertainment industry, construction industry, healthcare industry, automobile industry, and transportation industry. 3D Mapping market can be broadly classified based on their applications as 3D projection mapping, mapping and navigation, and other applications such as video gaming, automobiles and healthcare. In recent years, the global 3D mapping and 3D modeling market has experienced a surge in
Global Computer-Aided Design Market 2018 - Surface Modeling, Solid Modeling Tech …
Apex Market Reports, recently published a detailed market research study focused on the “Computer-Aided Design Market” across the global, regional and country level. The report provides 360° analysis of “Computer-Aided Design Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Computer-Aided Design on
Global Software & System Modeling Tools Market By Type - Standard Language-Based …
Researchmoz added Most up-to-date research on "Global Software & System Modeling Tools Market By Type - Standard Language-Based Modeling (SLBM) & Proprietary Language-Based Modeling (PLBM)" to its huge collection of research reports. This report studies the global Software & System Modeling Tools market, analyzes and researches the Software & System Modeling Tools development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the